Skip to content
NewsBlazeIN – Lifestyle
Author:
Ambrose Healthcare Ltd
Ambrose Healthcare Acquires AM-Pharma for Up to €161 Million, Expanding its Rare Disease Pipeline and Gaining a European Base
October 20, 2026